NCT06383182

Change in Serum Biomarkers After Endovascular Treatment for Acute Anterior Circulation Large Vessel Occlusion

Change in Serum Biomarkers After Endovascular Treatment for Acute Anterior Circulation Large Vessel Occlusion: a Prospective, Registry Study

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 200 (estimated)
• Sponsor: General Hospital of Shenyang Military Region · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: —

Summary

Acute ischaemic stroke (AIS) results in high rates of neurological morbidity and mortality, especially in patients with large vessel occlusion (LVO). Endovascular therapy (EVT) has been approved as the most effective treatment for patients with LVO , but about half patients undergoing EVT did not achieve good outcome. The mechanisms of poor prognosis are complex. How to accurately identify serological biomarkers related to patients' clinical prognosis is an important research topic nowadays.

Conditions

• Ischemic Stroke

Interventions

Type	Name	Description
PROCEDURE	endovascular treatment	all patients with anterior circulation large vessel occlusion will receive endovascular treatment.

Timeline

• Start date: 2024-07-02
• Primary completion: 2026-12-30
• Completion: 2026-12-30
• First posted: 2024-04-25
• Last updated: 2025-08-21

Locations

1 site across 1 country: China